Handmade quality · Free shipping over $75 · Explore the atelier

BI-3812 M2 proteins-interaction-inhibitor dihydrochloride CC90001 currently under clinical trials

SKU: 98616866992

4.9
USD165.00 USD214.00

Pay in 4 interest-free payments of $41.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

CC90001 currently under clinical trials for the Treatment of Idiopathic Pulmonary Fibrosis

Smiles: CN1CCN(CC1)C1=CC2NC(=NC=2C=C1)C1=CC2NC(=NC=2C=C1)C1C=CC(=CC=1)OCC

CCC1=CC2=C(CCC(=O)N2CC2C=CC(=CC=2)C2=CC=CC=C2C2NN=NN=2)C(CC)=N1

On the contrary YM155 shows no sufficient effect on protein expression of c-IAP2

BI-3812 M2 proteins-interaction-inhibitor dihydrochloride CC90001 currently under clinical trialsBI 3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of 3 nM; BI 3812 has antitumor activity. Product information CAS Number: 2166387 64 8 Molecular Weight: 558. 03 Formula: C26H32ClN7O5 Chemical Name: 1 [5 chloro 4 ({8 methoxy 1 methyl 3 [(methylcarbamoyl)methoxy] 2 oxo 1, 2 dihydroquinolin 6 yl}amino)pyrimidin 2 yl] N, N dimethylpiperidine 4 carboxamide Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products